Published in Healthcare Mergers, Acquisitions and Ventures Week, August 28th, 2004
Herring moderated the session, "Brand Building Alternatives in a Shrinking Megabrand Marketplace," which focused on the issues that markets today are challenged with impacting the bottom line without depending on the large revenue generated by mega-brands.
Mr. Herring was joined by executives from Noven Pharmaceuticals, Lupin Pharmaceuticals and Watson Pharmaceuticals for this case study review...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.